Non-invasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor Cells

[GranPaSmurf]

Combining the new test with prostate specific antigen (PSA) results can yield a diagnosis of aggressive prostate cancer that is more than 90% accurate, according to a Journal of Urology study.

This level of accuracy is higher than that of any other biomarker for prostate cancer...

auajournals.org/doi/10.1097...